CAS 388082-77-7
:ditosilato di lapatinib
Descrizione:
ditosilato di lapatinib è un inibitore della tirosina chinasi a piccole molecole utilizzato principalmente nel trattamento di alcuni tipi di cancro al seno, in particolare quelli che sono positivi per HER2. Funziona inibendo l'attività del recettore del fattore di crescita epidermico (EGFR) e HER2, che sono coinvolti nella proliferazione e sopravvivenza delle cellule tumorali. Il composto è caratterizzato dalla sua formula molecolare, che riflette la sua struttura complessa, inclusi un gruppo dicloroanilina e un gruppo solfonato che ne migliora la solubilità. ditosilato di lapatinib è tipicamente somministrato per via orale ed è noto per la sua capacità di penetrare la barriera ematoencefalica, rendendolo un'opzione potenziale per il trattamento delle metastasi cerebrali. La sua farmacocinetica include un'assorbimento moderato e una emivita che consente una somministrazione una volta al giorno. Gli effetti collaterali comuni possono includere diarrea, eruzione cutanea e nausea. Come per qualsiasi terapia mirata, il suo uso è spesso accompagnato da monitoraggio dell'efficacia e delle reazioni avverse, sottolineando l'importanza della medicina personalizzata in oncologia.
Formula:C43H42ClFN4O10S3
InChI:InChI=1/C29H26ClFN4O4S.2C6H6O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*7-10(8,9)6-4-2-1-3-5-6;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*1-5H,(H,7,8,9);1H2
InChI key:InChIKey=OZDXXJABMOYNGY-UHFFFAOYSA-N
SMILES:N(C=1C2=C(C=CC(=C2)C=3OC(CNCCS(C)(=O)=O)=CC3)N=CN1)C4=CC(Cl)=C(OCC5=CC(F)=CC=C5)C=C4.S(=O)(=O)(O)C1=CC=C(C)C=C1
Sinonimi:- 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, 4-methylbenzenesulfonate (1:2)
- 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, bis(4-methylbenzenesulfonate)
- Benzenesulfonic Acid
- Gw 572016F
- Hydrate
- Lapatinib Ditoyslate
- Lapatinib ditosylate anhydrous
- Lapatinib, Tykerb, GW572016
- N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine bis(4-methylbenzenesulfonate)
- N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6 -[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine h ydrate
- N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
- N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine benzenesulfonate hydrate (1:2:1)
- N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulfonate)
- Tykerb
- Tykerb N-{3-Chloro-4-[(3-fluorophenyl)-methoxy]-phenyl}-6-{5-{(2-methylsulfonylethy amino)-methyl]-2-furyl}-quinazolin-4-amine-benzenesulfonic acid
- Lapatinib ditosylate
- GW-572016 ditosylate
- Lapatinib (GW-572016) Ditosylate
- GW 572016 ditosylate
- N-{3-chloro-4-[(3-fluorobenzyl)oxyl]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylBenzenesulfonate)
- Lapatinib Ditosylate (Tykerb)
- N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(Methylsulfonyl)ethyl]aMino}Methyl)-2-furyl]-4-quinazolinaMine 4-Methylbenzenesulfonate (1:2)
- GW-572016F Ditosylate
- Tykerb Ditosylat
- Lapatinib ditasylate
- N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,di4-methylbenzenesulfonate
- Tykerb(lapatinib)
- Tykerb Ditosylate
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 prodotti.
Lapatinib Ditosylate
CAS:<p>Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).</p>Formula:C29H26ClFN4O4S·2C7H8O3SPurezza:99.41%Colore e forma:Yellow SolidPeso molecolare:925.46Lapatinib ditosylate
CAS:Formula:C43H42ClFN4O10S3Purezza:98%Colore e forma:SolidPeso molecolare:925.4608Lapatinib Ditosylate
CAS:Formula:C29H26ClFN4O4S·2C7H8O3SColore e forma:Yellow SolidPeso molecolare:581.06 2*172.20Lapatinib-d4 Ditosylate
CAS:Formula:C29H22D4ClFN4O4S·2C7H8O3SColore e forma:Light Yellow SolidPeso molecolare:585.08 2 172.20N-(3-Chloro-4-((3-Fluorobenzyl)Oxy)Phenyl)-6-(5-(((2-(Methylsulfonyl)Ethyl)Amino)Methyl)Furan-2-Yl)Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate)
CAS:<p>N-(3-Chloro-4-((3-Fluorobenzyl)Oxy)Phenyl)-6-(5-(((2-(Methylsulfonyl)Ethyl)Amino)Methyl)Furan-2-Yl)Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate)</p>Purezza:98%Peso molecolare:925.46g/molLapatinib Ditosylate
CAS:Formula:C29H26ClFN4O4S·2C7H8O3SPurezza:>98.0%(T)(HPLC)Colore e forma:White to Light yellow powder to crystalPeso molecolare:925.46Lapatinib Ditosylate
CAS:Prodotto controllato<p>Applications Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic.<br>References Kim, T.E., et al.: Drugs, 6, 886 (2003), Wood, E.R., et al.: Cancer Res., 64, 6652 (2004), Spector, N.L., et al.: J. Clin. Oncol., 23, 2502 (2005),<br></p>Formula:C29H26ClFN4O4S·2C7H8O3SColore e forma:YellowPeso molecolare:925.46Lapatinib tosylate anhydrous
CAS:<p>Inhibitor of EGFR (ErbB1) and HER2 (ErbB2) receptor tyrosine kinases. Used for sensitization of HER2-overexpressing cancer cells to radiation as well as chemotherapy to tamoxifen- and trastuzumab-resistant cell lines. The compound blocks signalling via Akt and mitogen-activated protein kinase (MAPK) pathways leading to reduced cell survival. In trastuzumab resistant cancer cells, it inhibits HER2 phosphorylation, prevents receptor ubiquitination and causes accumulation of inactive HER2 dimers on the cell surface.</p>Formula:C29H26ClFN4O4S•(C7H8O3S)2Purezza:Min. 95%Colore e forma:Off-White PowderPeso molecolare:925.46 g/mol






